ATP citrate lyase (ACLY), a critical enzyme in the metabolic reprogramming of many cancers, is the first rate‐limiting enzyme in the de novo synthesis of fatty acids and is widely expressed in a variety of mammalian tissues.10 The gene discussed is ACLY; the disease is cancer.